Prestige Consumer Healthcare
PBH
47.57
+1.13
+2.43%
Prestige Consumer Healthcare
US · PBH
#2733 by market cap
Listed 1970
47.57
+1.13
+2.43%
Live - 5344 symbols - heartbeat 497s ago
· 2026-10-07 19:54
After-hours
47.57
0.00%
- Market cap
- 2.25B
- P/E (TTM)i
- 13.32
- P/Bi
- 1.18
- EPSi
- 3.91
- Div yieldi
- 0.00%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on PBH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.2 percentage points.
Institutional ownership
- Held by institutions
- 114.63% -0.16pp
- Institutions
- 378 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund103.69%
Hedge Fund4.37%
Public Company4.12%
Individual/Insider1.41%
Government Pension Fund1.05%
Private Company0.69%
Insurance Company0.28%
Sovereign Wealth Fund0.19%
Family Office/Trust0.17%
Top holders as of 2026-06-30
BlackRock
16.53% · 7.83M sh
Ariel Investments, LLC
10.28% · 4.87M sh
Vanguard Portfolio Management, LLC
5.96% · 2.83M sh
Dimensional Fund Advisors
5.62% · 2.66M sh
Vanguard Capital Management, LLC
5.17% · 2.45M sh
Fuller & Thaler Asset Management, Inc.
4.92% · 2.33M sh
State Street Global Advisors
4.47% · 2.12M sh
Brandes Investment Partners, LP
4.33% · 2.05M sh
Kayne Anderson Rudnick Investment Management, LLC
3.95% · 1.87M sh
Geode Capital Management, LLC
3.32% · 1.57M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 21 buys · 28 sells
| Name | Role | Stake |
|---|---|---|
| Ronald Lombardi | Chairperson & CEO | 0.79% |
| Christine Sacco | Chief Financial Officer | 0.15% |
| John Byom | Lead Independent Director | 0.10% |
| William P'Pool | Senior Vice President | 0.09% |
| Jeffrey Zerillo | Officer | 0.07% |
| Sheila Hopkins | Independent Director | 0.06% |
| Adel Mekhail | Executive Vice President of Marketing & Sales | 0.04% |
| Mary Fritz | Senior Vice President of Quality & Regulatory Affairs | 0.03% |
| Dawn Zier | Independent Director | 0.03% |
| Clesteen Clark | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-03 | John Byom | Lead Independent Director | Other Acquisition | +2,981 | -- |
| 2026-08-03 | Clesteen Clark | Independent Director | Other Acquisition | +2,981 | -- |
| 2026-08-03 | Dawn Zier | Independent Director | Other Acquisition | +2,981 | -- |
| 2026-08-03 | James D'Arecca | Independent Director | Other Acquisition | +2,981 | -- |
| 2026-08-03 | John Kelly | Director | Other Acquisition | +2,981 | -- |
| 2026-05-10 | Jeffrey Zerillo | Officer | Open Market Disposition | -351 | $52.28 |
| 2026-05-06 | Christine Sacco | Chief Financial Officer | Sale to Issuer | -991 | $54.59 |
| 2026-05-06 | Ronald Lombardi | Chairperson & CEO | Sale to Issuer | -2,543 | $54.59 |
| 2026-05-06 | Jeffrey Zerillo | Officer | Sale to Issuer | -351 | $54.59 |
| 2026-05-06 | Jeffrey Zerillo | Officer | Open Market Disposition | -305 | $54.36 |
| 2026-05-06 | Adel Mekhail | Executive Vice President of Marketing & Sales | Sale to Issuer | -487 | $54.59 |
| 2026-05-05 | Jeffrey Zerillo | Officer | Intent to Sell (Form 144) | -1,207 | $54.99 |
| 2026-05-04 | Christine Sacco | Chief Financial Officer | Sale to Issuer | -1,267 | $55.75 |
| 2026-05-04 | Ronald Lombardi | Chairperson & CEO | Sale to Issuer | -2,197 | $55.75 |
| 2026-05-04 | Jeffrey Zerillo | Officer | Sale to Issuer | -307 | $55.75 |
| 2026-05-04 | Jeffrey Zerillo | Officer | Private Disposition | -1,207 | $54.99 |
| 2026-05-04 | Jeffrey Zerillo | Officer | Open Market Disposition | -346 | $55.32 |
| 2026-05-03 | Christine Sacco | Chief Financial Officer | Sale to Issuer | -3,434 | $55.31 |
| 2026-05-03 | Christine Sacco | Chief Financial Officer | Other Acquisition | +7,008 | -- |
| 2026-05-03 | Christine Sacco | Chief Financial Officer | Other Acquisition | +11,976 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.